Acquired Aplastic Anemia.docx

上传人:b****2 文档编号:2373481 上传时间:2023-05-03 格式:DOCX 页数:50 大小:83.91KB
下载 相关 举报
Acquired Aplastic Anemia.docx_第1页
第1页 / 共50页
Acquired Aplastic Anemia.docx_第2页
第2页 / 共50页
Acquired Aplastic Anemia.docx_第3页
第3页 / 共50页
Acquired Aplastic Anemia.docx_第4页
第4页 / 共50页
Acquired Aplastic Anemia.docx_第5页
第5页 / 共50页
Acquired Aplastic Anemia.docx_第6页
第6页 / 共50页
Acquired Aplastic Anemia.docx_第7页
第7页 / 共50页
Acquired Aplastic Anemia.docx_第8页
第8页 / 共50页
Acquired Aplastic Anemia.docx_第9页
第9页 / 共50页
Acquired Aplastic Anemia.docx_第10页
第10页 / 共50页
Acquired Aplastic Anemia.docx_第11页
第11页 / 共50页
Acquired Aplastic Anemia.docx_第12页
第12页 / 共50页
Acquired Aplastic Anemia.docx_第13页
第13页 / 共50页
Acquired Aplastic Anemia.docx_第14页
第14页 / 共50页
Acquired Aplastic Anemia.docx_第15页
第15页 / 共50页
Acquired Aplastic Anemia.docx_第16页
第16页 / 共50页
Acquired Aplastic Anemia.docx_第17页
第17页 / 共50页
Acquired Aplastic Anemia.docx_第18页
第18页 / 共50页
Acquired Aplastic Anemia.docx_第19页
第19页 / 共50页
Acquired Aplastic Anemia.docx_第20页
第20页 / 共50页
亲,该文档总共50页,到这儿已超出免费预览范围,如果喜欢就下载吧!
下载资源
资源描述

Acquired Aplastic Anemia.docx

《Acquired Aplastic Anemia.docx》由会员分享,可在线阅读,更多相关《Acquired Aplastic Anemia.docx(50页珍藏版)》请在冰点文库上搜索。

Acquired Aplastic Anemia.docx

AcquiredAplasticAnemia

AcquiredAplasticAnemia

Young,NealS.MD

AuthorInformation

FromtheNationalHeart,Lung,andBloodInstitute,NationalInstitutesofHealth,Bethesda,Maryland.

Forauthoraffiliationandcurrentaddress,seeendoftext.

Acknowledgments:

TheauthorthanksDrs.JaroslawMaciejewski,JohnBarrett,ElaineSloand,andCynthiaDunbarfortheircarefulreadingofthemanuscript.

GrantSupport:

Dr.YoungissupportedentirelybyintramuralfundsfromtheNationalHeart,Lung,andBloodInstitute.

RequestsforSingleReprints:

NealS.Young,MD,Building10,Room7C103,NationalInstitutesofHealth,9000RockvillePike,Bethesda,MD20892-1652.

BacktoTop

 

Abstract

 

Inaplasticanemia,hematopoiesisfails:

Bloodcellcountsareextremelylow,andthebonemarrowappearsempty.Thepathophysiologyofaplasticanemiaisnowbelievedtobeimmune-mediated,withactivedestructionofblood-formingcellsbylymphocytes.Theaberrantimmuneresponsemaybetriggeredbyenvironmentalexposures,suchastochemicalsanddrugsorviralinfectionsand,perhaps,endogenousantigensgeneratedbygeneticallyalteredbonemarrowcells.Inpatientswithpost-hepatitisaplasticanemia,antibodiestotheknownhepatitisvirusesareabsent;theunknowninfectiousagentmaybemorecommonindevelopingcountries,whereaplasticanemiaoccursmorefrequentlythanitdoesintheWest.

 

Thesyndromeparoxysmalnocturnalhemoglobinuria(PNH)isintimatelyrelatedtoaplasticanemiabecausemanypatientswithbonemarrowfailurehaveanincreasedpopulationofabnormalcells.InPNH,anentireclassofproteinsisnotdisplayedonthecellsurfacebecauseofanacquiredX-chromosomegenemutation.ThePNHcellsmayhaveaselectiveadvantageinresistingimmuneattack.Incontrast,thediseasemyelodysplasiacanbeconfusedwithaplasiaandcanalsoevolvefromaplasticanemia.Theoccurrenceofcytogeneticabnormalitiesinpatientsyearsafterpresentationimpliesthatgenomicinstabilityisafeatureofthisimmune-mediateddisease.

 

Aplasticanemiacanbeeffectivelytreatedbystem-celltransplantationorimmunosuppressivetherapy.Transplantationiscurativebutisbestusedforyoungerpatientswhohavehistocompatiblesiblingdonors.Antithymocyteglobulinandcyclosporinerestorehematopoiesisinapproximatelytwothirdsofpatients.However,recoveryofbloodcellcountisoftenincomplete,recurrentpancytopeniarequiresretreatment,andsomepatientsdeveloplatecomplications(especiallymyelodysplasia).

 

 

Aplasticanemia’slonghistory,fromitsearlydescriptionbyEhrlich

(1)attheendofthe19thcentury,andthesimplicityofitspathology,anemptybonemarrow,havemadeittheparadigmofhematopoieticfailuresyndromes.Aplasticanemiaisnowincreasinglyrecognizedasbeingcloselyrelatedtootherhematologicdiseases(Figure1).Erythrocytes,granulocytes,andplatelets,whicharenormallyproducedinthebonemarrow,decreasetodangerouslylowlevels.Bloodcellcountsdeterminepresentationandprognosis.Anemialeadstofatigue,dyspnea,andcardiacsymptoms;thrombocytopeniatobruisingandmucosalbleeding;andneutropeniatosharplyincreasedsusceptibilitytoinfection.Whenpatientsaretreatedwithtransfusionsandantibioticsalone,survivalratesarepoorandrelatedtotheseverityofthepancytopenia,asdefinedbythepresenceoftwoofthreecriteria:

aneutrophilcountlessthan0.5×109cells/L,aplateletcountlessthan20×109cells/L,andareticulocytecountlessthan1%.Whentheneutrophilcountislessthan0.2×109cells/L,thediseaseischaracterizedasverysevere.Intheearly20thcentury,patientsoftendiedquicklyofheartfailure,profusehemorrhage,oroverwhelminginfection.Inthemoderneraoferythrocyteandplatelettransfusions,themostcommoncausesofdeatharerecurrentbacterialsepsisorfungalinvasionofcriticalorganssecondarytorefractorygranulocytopenia.

Figure1

Historically,aplasticanemiahasbeenstronglyassociatedwithexposuretochemicalsanddrugsintheenvironment,givingthediseaseasocialimpactdisproportionatetoitsincidence

(2).TherecognitionofbonemarrowfailureinworkersexposedtobenzeneledtoheroicindustrialhygienecrusadesbyAliceHamiltonandHarrisonMartlandintheUnitedStatesinthe1920sand1930s.Inthelate1940sandearly1950s,anepidemicofaplasticanemiaappearedtofollowtheintroductionofchloramphenicol,andthediseasehasbeenlinkedtomanyclassesofpharmaceuticalswidelyusedinmedicalpractice(Table).Becauseaplasticanemiahasbecomesuchafeareddisorderasaresultofitsassociationwithcommondruguse,evenafewcasescanhaveaprofoundeffectonnewdrugdevelopmentbythepharmaceuticalindustry.Also,thisbelievedassociationwithnumerous,diversepossiblecauses,fromchemicalsanddrugstohepatitis,infectiousmononucleosis,pregnancy,andcollagenvascularprocesses(forexample,eosinophilicfasciitis),hasledtothebeliefthattherealsoarenumerousanddifferentmechanismsofdisease.

Table.DrugsAssocia...

However,wenowhaveaplausible,unifiedmodelofthepathophysiologyofaplasticanemia,drawnfrombothcompellingclinicalobservationsoftherapeuticefficacyandsystematiclaboratoryexperimentation.Theearly,successfuluseofbonemarrowtransplantationtocureaplasticanemiaimplicatedastem-celldeficiency.Later,responsestoimmunosuppressivetherapiespointedtoanimmunemechanismofhematopoieticfailure.Asaplasticanemiaisprogressivelydemystified,questionsofsomebiologicalinterestemerge.Thesearerelevanttobonemarrowfailureaswellastoourconceptionsofautoimmunediseasesofotherorgansystemsandtotherelationshipofimmunemechanismstomalignanttransformation.

 

BacktoTop

 

ImmunePathophysiologyofAplasticAnemia

 

MostcasesofacquiredaplasticanemiacanbepathophysiologicallycharacterizedasT-cell–mediated,organ-specificdestructionofbonemarrowhematopoieticcells(4).Inanindividualpatient,theaberrantimmuneresponsecansometimesbelinkedtoaviralinfectionortodrugorchemicalexposure(Figure2).Thereismuchlessevidenceforothermechanisms,suchasdirecttoxicityforstemcellsoradeficiencyofstromal-cellorhematopoieticgrowthfactorfunction.Furthermore,thevariabilityinclinicalcourseandresponsetotreatmentcanbeexplainedbythequantitativedegreeofstem-celldestructionandqualitativevariationsinimmuneresponse.

Figure2

BacktoTop

 

HematopoieticFailure

 

Thatfailureofbloodcellproductionwasresponsiblefortheemptybonemarrowwasaprescientconclusionoftheearliestobserversofthe“yellowfat”ofthebonyspacesandtheabsenceofthemorphologicallydiverseprecursorsofmaturebloodelements—stillsostrikingonexaminationofbonemarrowaspiratesmearsorcorebiopsyspecimens(5).Magneticresonanceimagingofthevertebraeshowsuniformreplacementofmarrowwithfat.Immaturehematopoieticcellscanalsobequantitatedbyfluorescent-activatedflowcytometry,whichcandetecttheCD34cellantigen,anadhesionproteinpresentonlessthan1%ofnormalbonemarrow.CD34cellsarealmostabsentinaplasticanemia.Progenitorcellscapableofformingerythroid,myeloid,andmegakaryocyticcoloniesintissueculturearegreatlyreduced,andassaysofveryprimitive,quiescent,hematopoieticcellsthatarecloselyrelatedifnotidenticaltostemcellsshowasimilarconsistentandseveredeficit.Byextrapolationfromsuchfunctionalstudiesofaplasticbonemarrow,itislikelythatpatientspresentwithpancytopeniawhenstem-cellandprogenitor-cellpopulationshavedecreasedtoapproximately1%orlessofnormal.Suchaprofounddeficiencyhasimportantqualitativeconsequences,asreflectedintheshortenedtelomerelengthofgranulocytesofpatientswithaplasticanemia(6).

 

BacktoTop

 

ImmuneDestruction

 

Theefficiencyofimmunesystemdestructionofblood-formingcellsisobviousin“runtdisease”inanimalsandintransfusion-associatedgraft-versus-hostdisease(GVHD)inhumans(7).Inthesesyndromes,smallnumbersofalloreactiveTcellsproducefatalaplasticanemia,andinthemousemodel,weknowthatstem-celldestructionisrapidandalmostcomplete.Muchlaboratorydatasupportthehypothesisthat,inmostpatientswithacquiredaplasticanemia,lymphocytesareresponsibleforthedestructionofthehematopoieticcellcompartment(4).

 

Earlyexperimentsshowedthatthepatients’lymphocytessuppressedhematopoiesis.Thesecellsproducedasoluble,inhibitoryfactorthatwaseventuallyidentifiedasinterferon-[gamma].ActivationofaTH1-typeT-cellresponsehasbeeninferredfromimmunophenotypiccharacterizationofTcellsandexcessiveproductionofinterferon,tumornecrosisfactor,andinterleukin-2.Detectionofintracellularinterferon-[gamma]inpatientsamplesbyflowcytometrymaycorrelatewithresponsivenesstoimmunosuppressivetherapyandmaypredictrelapse(8).Alteredimmunityresultsindestruction,specificallyFas-mediatedCD34celldeath,andinactivationofintracellularpathwaysleadingtocell-cyclearrest.Immunityislocalandhasbeenmodeledintissueculturewhenlowconcentrationsofinterferon-[gamma]aresecretedintothemarrowmicroenvironment.Inananimalmodel,bonemarrowfailureafterinjectionofalloreactivelymphocytescanbepreventedbytreatmentwithamonoclonalantibodytointerferon-[gamma](9).

 

Thenatureoftheantigenorantigensdrivingthepathologicimmuneresponseisunknown.Atthemolecularlevel,lymphocytesinaplasticanemiashowsimilaritytoTcellsinmultiplesclerosis,diabetes,andotherrelatedillnesses.Characterizat

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 解决方案 > 学习计划

copyright@ 2008-2023 冰点文库 网站版权所有

经营许可证编号:鄂ICP备19020893号-2